Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis

被引：68

作者：

Liew, Jean W. ^{[1
]}

Ramiro, Sofia ^{[2
]}

Gensler, Lianne S. ^{[3
]}

机构：

[1] Univ Washington, 1959 NE Pacific St,BB561, Seattle, WA 98195 USA

[2] Leiden Univ, Med Ctr, NL-2333 ZA Leiden, Netherlands

[3] Univ Calif San Francisco, 400 Parnassus Ave,Box 0326, San Francisco, CA 94143 USA

来源：

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2018年 / 32卷 / 03期

关键词：

Ankylosing spondylitis; Axial spondyloarthritis; Psoriatic arthritis; Cardiovascular disease; Atherosclerosis; Arrhythmias; Aortic root; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTIMA-MEDIA THICKNESS; INCREASED ARTERIAL STIFFNESS; ALPHA INHIBITOR TREATMENT; RISK-FACTORS; RHEUMATOID-ARTHRITIS; METABOLIC SYNDROME; SUBCLINICAL ATHEROSCLEROSIS; CEREBROVASCULAR DISEASES; ENDOTHELIAL DYSFUNCTION;

D O I：

10.1016/j.berh.2019.01.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The cardiovascular burden in inflammatory rheumatic diseases is well recognized. Recently, this burden has been highlighted in ankylosing spondylitis (also known as radiographic axial spondy-loarthritis) and psoriatic arthritis. We review the cardiovascular morbidity and mortality in these diseases, as well as the prevalence and incidence of traditional cardiovascular risk factors. We examine the contribution of anti-inflammatory therapy with nonsteroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs, and TNF inhibitors on the cardiovascular risk profile. Finally, we examine the available recommendations for the management of cardiovascular comorbidity, as they apply to the spondyloarthritis population. (C) 2019 Published by Elsevier Ltd.

引用

页码：369 / 389

页数：21

共 128 条

[1] EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update [J].

Agca, R. ;

Heslinga, S. C. ;

Rollefstad, S. ;

Heslinga, M. ;

McInnes, B. ;

Peters, M. J. L. ;

Kvien, T. K. ;

Dougados, M. ;

Radner, H. ;

Atzeni, F. ;

Primdahl, J. ;

Sodergren, A. ;

Jonsson, S. Wallberg ;

van Rompay, J. ;

Zabalan, C. ;

Pedersen, T. R. ;

Jacobsson, L. ;

de Vlam, K. ;

Gonzalez-Gay, M. A. ;

Semb, A. G. ;

Kitas, G. D. ;

Smulders, Y. M. ;

Szekanecz, Z. ;

Sattar, N. ;

Symmons, D. P. M. ;

Nurmohamed, M. T. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) :17-28

[2] The Effects of 5-year Etanercept Therapy on Cardiovascular Risk Factors in Patients with Psoriatic Arthritis [J].

Agca, Rabia ;

Heslinga, Maaike ;

Kneepkens, Eva L. ;

van Dongen, Carlo ;

Nurmohamed, Michael T. .

JOURNAL OF RHEUMATOLOGY, 2017, 44 (09) :1362-1368

[3] Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study [J].

Ahlehoff, O. ;

Gislason, G. H. ;

Charlot, M. ;

Jorgensen, C. H. ;

Lindhardsen, J. ;

Olesen, J. B. ;

Abildstrom, S. Z. ;

Skov, L. ;

Torp-Pedersen, C. ;

Hansen, P. R. .

JOURNAL OF INTERNAL MEDICINE, 2011, 270 (02) :147-157

[4] Improved survival in psoriatic arthritis with calendar time [J].

Ali, Yaser ;

Tom, Brian D. M. ;

Schentag, Catherine T. ;

Farewell, Vernon T. ;

Gladman, Dafna D. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (08) :2708-2714

[5] Effect of 1-Year Anti-TNF-α Therapy on Aortic Stiffness, Carotid Atherosclerosis, and Calprotectin in Inflammatory Arthropathies: A Controlled Study [J].

Angel, Kristin ;

Provan, Sella A. ;

Fagerhol, Magne K. ;

Mowinckel, Petter ;

Kvien, Tore K. ;

Atar, Dan .

AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (06) :644-650

[6] 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J].

Catapano, Alberico L. ;

Graham, Ian ;

De Backer, Guy ;

Wiklund, Olov ;

Chapman, M. John ;

Drexel, Heinz ;

Hoes, Arno W. ;

Jennings, Catriona S. ;

Landmesser, Ulf ;

Pedersen, Terje R. ;

Reiner, Zeljko ;

Riccardi, Gabriele ;

Taskinen, Marja-Riita ;

Tokgozoglu, Lale ;

Verschuren, W. M. Monique ;

Vlachopoulos, Charalambos ;

Wood, David A. ;

Luis Zamorano, Jose .

ATHEROSCLEROSIS, 2016, 253 :281-344

[7] Increased mortality in ankylosing spondylitis is related to disease activity [J].

Bakland, Gunnstein ;

Gran, Jan Tore ;

Nossent, Johannes C. .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (11) :1921-1925

[8] Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis: How Far Are We from the Truth? [J].

Belur, Agastya D. ;

Mehta, Nehal N. .

JOURNAL OF RHEUMATOLOGY, 2018, 45 (02) :150-152

[9] Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study [J].

Bengtsson, Karin ;

Forsblad-d'Elia, Helena ;

Lie, Elisabeth ;

Klingberg, Eva ;

Dehlin, Mats ;

Exarchou, Sofia ;

Lindstrom, Ulf ;

Askling, Johan ;

Jacobsson, Lennart T. H. .

ARTHRITIS RESEARCH & THERAPY, 2017, 19

[10] CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up [J].

Berg, Inger Jorid ;

Semb, Anne Grete ;

van der Heijde, Desiree ;

Kvien, Tore K. ;

Olsen, Inge C. ;

Dagfinrud, Hanne ;

Provan, Sella A. .

ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (08) :1562-1566

← 1 2 3 4 5 6 7 8 9 10 →